Hematologic MalignanciesNCT01351545
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
An observational study of Hematologic Malignancies and Inherited Disorders of Metabolism, run by Center for International Blood and Marrow Transplant Research at 142 sites in United States.
Trial summary
This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Hematologic Malignancies, Inherited Disorders of Metabolism, Inherited Abnormalities of Platelets
- What is being tested?
- A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs)
- How many people
- 99,999 participants
- Where
- 142 sitesUnited States
- Study dates
- Oct 2011to Oct 2041
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Recipients of unlicensed cryopreserved cord blood units who are being treated as U.S. transplant centers.
Who may be able to join
- Disorders affecting the hematopoietic system that are inherited, acquired, or result from myeloablative treatment
- Signed informed consent (and signed assent, if applicable) obtained prior to study enrollment
- Pediatric and adult patients of any age
Who cannot join
- Patients who are receiving only licensed CBUs
- Cord blood transplant recipients at international transplant centers
- Patients who are enrolled on another IND protocol to access the unlicensed CBU(s)
- Patients whose selected unlicensed CBU(s) will be more than minimally manipulated
Trial locations and contacts
142 sites in 1 country. Contact the study team or a site near you to ask about taking part.
Elizabeth Fosberg, B.A. contact
142 sites in 1 country
United States142 sites, 113 recruiting
- Recruiting
Childrens Hospital Medical Center of Akron
Akron, Ohio, 44308
Megan Sampson, MD, msampson@akronchildrens.org
Megan Sampson, MD
- Terminated
Amarillo Blood and Marrow Transplant Program
Amarillo, Texas, 79106
- Recruiting
University of Michigan
Ann Arbor, Michigan, 48109
Jessica Yu, jjxyu@med.umich.edu
Gregory Yanik, M.D.
- Recruiting
Children's Healthcare of Atlanta
Atlanta, Georgia, 30322
Alan Bidgoli, MD, 404-875-4197, alan.bidgoli@choa.org
Alan Bidgoli, MD
- Terminated
Emory University Hospital
Atlanta, Georgia, 30322
- Recruiting
Northside Hospital
Atlanta, Georgia, 30342
Scott Solomon, MD, ssolomon@bmtga.com
Scott Solomon, MD
- Recruiting
Georgia Cancer Center at Augusta University Health
Augusta, Georgia, 30912
Vamsi K Kota, MD, vkota@augusta.edu
Vamsi K Kota, MD
- Recruiting
Children's Hospital Colorado
Aurora, Colorado, 80045
Michael Verneris, MD, MICHAEL.VERNERIS@CUANSCHUTZ.EDU
Michael Verneris, MD
- Recruiting
University of Colorado Hospital
Aurora, Colorado, 80045
Jonathan Gutman, MD, jonathan.gutman@ucdenver.edu
Jonathan Gutman, MD
- Withdrawn
Greenebaum Cancer Center - University of Maryland
Baltimore, Maryland, 21201
- Recruiting
Johns Hopkins
Baltimore, Maryland, 21287
Allen Chen, MD, PhD, allenchen@jhmi.edu
Allen Chen, MD, PhD
- Withdrawn
Indiana Blood & Marrow Transplantation
Beech Grove, Indiana, 46107
- Recruiting
Nih/Niaid
Bethesda, Maryland, 20892-1456
Elizabeth Kang, MD, ekang@niaid.nih.gov
Elizabeth Kang, MD
- Active, not recruiting
NIH/NCI
Bethesda, Maryland, 20892
- Recruiting
Nih/Nhlbi
Bethesda, Maryland, 20892
Richard Childs, MD, childsr@nih.gov
Richard Childs, MD
- Recruiting
University of Alabama at Birmingham
Birmingham, Alabama, 35233
Joseph Chewning, MD, jchewning@peds.uab.edu
Joseph Chewning, MD
- Recruiting
Tufts Medical Center
Boston, Massachusetts, 02111
Andreas Klein, MD, 617-636-8884, aklein2@tuftsmedicalcenter.org
Andreas Klein, MD
- Suspended
Massachusetts General Hospital
Boston, Massachusetts, 02114
- Recruiting
Beth Israel Deaconess
Boston, Massachusetts, 02215
David Avigan, MD, davigan@bidmc.harvard.edu
David Avigan, MD
- Recruiting
Dana Farber Cancer Institute
Boston, Massachusetts, 02215
Corey Cutler, MD, cscutler@partners.org
Cory Cutler, MD
- Recruiting
Nemours - Alfred I. duPont Hospital for Children
Brandywine, Delaware, 19803
Emi Caywood, MD, ecaywood@nemours.org
Emi Caywood, MD
- Recruiting
Roswell Park Cancer Institute
Buffalo, New York, 14263
Kanwaldeep Mallhi, MD, (716) 845-2333, Kanwaldeep.Mallhi@RoswellPark.org
Kanwaldeep Mallhi, MD
- Recruiting
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599
Anson Snow, MD, 984-974-1000, Anson.Snow@unchealth.unc.edu
Anson Snow, MD
- Recruiting
Medical University of South Carolina
Charleston, South Carolina, 29425
Michelle Hudspeth, MD, 843-792-2957, hudspeth@musc.edu
Michelle Hudspeth, MD
- Recruiting
Levine Children's Hospital
Charlotte, North Carolina, 28203
Jeffrey Huo, MD, Jeffrey.Huo@carolinashealthcare.org
Michelle Hyland, Michelle.Hyland@carolinashealthcare.org
- Recruiting
University of Virginia
Charlottesville, Virginia, 22908
Karen Ballen, MD, KB3TC@hscmail.mcc.virginia.edu
Karen Ballen, MD
- Recruiting
Northwestern Memorial Hospital
Chicago, Illinois, 60611
Kehinde Adekola, MD, kehinde-adekola@northwestern.edu
Kehinde Adekola, MD
- Recruiting
Rush University Medical Center
Chicago, Illinois, 60612
Sunita Nathan, MD
Sunita Nathan, MD
- Recruiting
University of Illinois at Chicago
Chicago, Illinois, 60612
Damiano Rondelli, MD, drond@uic.edu
Damiano Rondelli, MD
- Recruiting
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, 60614
Sonali Chaudhury, MD, schaudhury@luriechildrens.org
Sonali Chaudhury, MD
- Recruiting
University of Chicago
Chicago, Illinois, 60637
James LaBelle, MD, PhD, jlabelle@peds.bsd.uchicago.edu
James LaBelle, MD, PhD
- Recruiting
Cincinnati Children's Hospital
Cincinnati, Ohio, 45229
Stella Davies, MD, stella.davies@cchmc.org
Stella Davies, MD
- Withdrawn
The Jewish Hospital
Cincinnati, Ohio, 45230
- Recruiting
University Hospitals Case Medical Center
Cleveland, Ohio, 44106
Hillard Lazarus, MD, hillard.lazarus@case.edu
Hillard Lazarus, MD
- Recruiting
Cleveland Clinic
Cleveland, Ohio, 44195
Claudio Brunstein, MD, (216) 445-0910, brunstc@ccf.org
Claudio Brunstein, MD
- Recruiting
Nationwide Children's Hospital
Columbus, Ohio, 43205
Rolla Abu-Arja, MD, rolla.abu-arja@nationwidechildrens.org
Rolla Abu-Arja, MD
- Recruiting
The Arthur G. James Cancer Hospital/The Ohio State University Medical Center
Columbus, Ohio, 43210
Sumithira Vasu, MD, sumithira.vasu@osumc.edu
Sumithira Vasu, MD
- Recruiting
Medical City Dallas
Dallas, Texas, 75230
Vikas Bhushan, MD, vikas.bhushan@usoncology.com
Vikas Bhushan, MD
- Recruiting
Children's Medical Center Dallas
Dallas, Texas, 75235
Victor Aquino, MD, Victor.aquino@utsouthwestern.edu
Victor Aquino, MD
- Withdrawn
University of Texas Southwestern Medical Center
Dallas, Texas, 75390
- Recruiting
Presbyterian St. Luke's/Colorado Blood Cancer Institute
Denver, Colorado, 80218
Alireza Eghtedar, MD, alireza.eghtedar@healthonecares.com
Alireza Eghtedar, MD
- Recruiting
Children's Hospital of Michigan
Detroit, Michigan, 48201
Sureyya Savasan, MD, ssavasan@med.wayne.edu
Sureyya Savasan, MD
- Suspended
Karmanos Cancer Institute
Detroit, Michigan, 48201
- Recruiting
Henry Ford Health System
Detroit, Michigan, 48202
Nalini Janakiraman, MD, njanaki1@hfhs.org
Nalini Janakiraman, MD
- Recruiting
City of Hope
Duarte, California, 91010
Monzr Al Malki, MD, malmalki@coh.org
Monzr Al Malki, MD
- Recruiting
Duke University Medical Center
Durham, North Carolina, 27705
Joanne Kurtzberg, MD, kurtz001@mc.duke.edu
Joanne Kurtzberg, MD
- Recruiting
Zachary & Elizabeth Fisher Bone Marrow Transplant Program (Brooke Army Medical Center)
Fort Sam Houston, Texas, 78234
Gilbert Ancira, MD, 210-916-4808, gilbert.p.ancira.mil@health.mil
Gilbert Ancira, MD
- Recruiting
Cook Children's Hospital
Fort Worth, Texas, 76104
Gretchen Eames, MD, gretchen.eames@cookchildrens.org
Gretchen Eames, MD
- Recruiting
University of Florida Shands Medical Center
Gainesville, Florida, 32610
Jordan Milner, MD, 352-273-9120, jordan.milner@ufl.edu
Jordan Milner, MD
- Recruiting
Banner MD Anderson Cancer Center
Gilbert, Arizona, 85234
Matthew Ulrickson, MD, 480-256-3223, Matthew.Ulrickson@bannerhealth.com
Matthew Ulrickson, MD
- Recruiting
Children's Hospital of Los Angeles
Glendale, California, 91204
Neena Kapoor, MD, nkapoor@chla.usc.edu
Neena Kapoor, MD
- Recruiting
Helen DeVos Children's Hospital
Grand Rapids, Michigan, 49503
Troy Quigg, MD, troy.quigg@spectrumhealth.org
Troy Quigg, MD
- Recruiting
Spectrum Health
Grand Rapids, Michigan, 49503
Aly Abdel-Mageed, MD, aly.mageed@helendevoschildrens.org
Aly Abdel-Mageed, MD
- Recruiting
Hackensack University Medical Center
Hackensack, New Jersey, 07601
Alfred Gillio, MD, agillio@humed.com
Alfred Gillio, MD
- Recruiting
Penn State Milton S. Hershey Cancer Center
Hershey, Pennsylvania, 17033
Shin Mineishi, MD, smineishi@pennstatehealth.psu.edu
Shin Mineishi, MD
- Recruiting
Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, 96813
Randal Wada, MD, randalw@hawaii.edu
Randal Wada, MD
- Recruiting
M.D. Anderson Cancer Center
Houston, Texas, 77030
Elizabeth Shpall, MD, eshpall@mdanderson.org
Elizabeth Shpall, MD
- Recruiting
Texas Children's Hospital - Baylor Medical Center
Houston, Texas, 77030
George Carrum, MD, 832-824-7695, gcarrum@houstonmethodist.org
George Carrum, MD
- Recruiting
Indiana University/Riley Hospital for Children
Indianapolis, Indiana, 46202
Jodi Skiles, MD, jskiles@iupui.edu
Jodi Skiles, MD
- Recruiting
University of Iowa
Iowa City, Iowa, 52242
Margarida Silverman, MD, margarida-silverman@uiowa.edu
Margarida Silverman, MD
- Recruiting
Univeristy of Mississippi Medical Center
Jackson, Mississippi, 39216
Carter Milner, MD, 601-984-5613, capayne@umc.edu
Carter Milner, MD
- Recruiting
Nemours Children's Hospital - Mayo Jacksonville
Jacksonville, Florida, 32207
Edward Ziga, MD, 904-697-2047, Edward.ziga@nemours.org
Edward Ziga, MD
- Withdrawn
Mayo Clinic - Jacksonville
Jacksonville, Florida, 32224
- Recruiting
Children's Mercy Hospital and Clinics
Kansas City, Missouri, 64108
Erin Hall, MD, 816-302-6808, emhall@cmh.edu
Erin Hall, MD
- Recruiting
Scripps Green Hospital
La Jolla, California, 92037
James R Mason, MD, mason.james@scrippshealth.org
James R Mason, MD
- Recruiting
University of California San Diego
La Jolla, California, 92093
Kaitlyn Dykes, MD, 8588226600, kcdykes@health.ucsd.edu
Kaitlyn Dykes, MD
- Recruiting
North Shore University Hospital
Lake Sucess, New York, 11042
Ruthee L Bayer, MD, rbayer@nshs.edu
Ruthee L Bayer, MD
- Recruiting
Arkansas Children's Hospital
Little Rock, Arkansas, 72202
Jason Farrar, MD, JEFarrar@uams.edu
- Recruiting
Loma Linda University Cancer Center
Loma Linda, California, 92350
Hisham Abdel-Azim, MD, habdelazim@llu.edu
Hisham Abdel-Azim, MD
- Recruiting
UCLA
Los Angeles, California, 90095
Gary Schiller, MD, 310-206-5755, gschiller@mednet.ucla.edu
Gary Schiller, MD
- Recruiting
University of Louisville Hospital - James Brown Cancer Center
Louisville, Kentucky, 40202
Mohamed Hegazi, MD, mohamed.hegazi@louisville.edu
Mohamed Hegazi, MD
- Withdrawn
Southwest Cancer Treatment & Research Center
Lubbock, Texas, 79415
- Recruiting
University of Wisconsin - Madison
Madison, Wisconsin, 53792
Kenneth DeSantes, MD, kbdesantes@pediatrics.wisc.edu
Kenneth Desantes, MD
- Recruiting
Loyola University Medical Center
Maywood, Illinois, 60153
Patrick Hagen, MD, patrick.hagen@lumc.edu
Patrick Hagen, MD
- Active, not recruiting
Methodist Healthcare Blood and Marrow Transplant Center
Memphis, Tennessee, 38104
- Recruiting
St. Jude Childrens Research Hospital
Memphis, Tennessee, 38105
Renee Madden, MD, renee.madden@stjude.org
Renee Madden, MD
- Active, not recruiting
University of Miami (adult)
Miami, Florida, 33136
- Recruiting
University of Miami (peds)
Miami, Florida, 33136
Edward Ziga, MD, MPH, e.ziga@med.miami.edu
Edward Ziga, MD, MPH
- Recruiting
Niklaus Children's Hospital
Miami, Florida, 33155
Jorge Galvez-Silva, MD, jorgericardo.galvezsilva@nicklaushealth.org
Jorge Galvez-Silva, MD
- Recruiting
Children's Hospital of Wisconsin
Milwaukee, Wisconsin, 53226
David Margolis, MD, dmargoli@mcw.edu
David Margolis, MD
- Active, not recruiting
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226
- Recruiting
West Virginia University
Morgantown, West Virginia, 26506-8110
Lauren Veltri, MD, lveltri@hsc.wvu.edu
Lauren Veltri, MD
- Suspended
Sarah Cannon BMT Program
Nashville, Tennessee, 37203
- Withdrawn
VA Tennessee Valley Healthcare System
Nashville, Tennessee, 37212
- Recruiting
Vanderbilt University
Nashville, Tennessee, 37232
Michael Byrne, MD, michael.byrne@vumc.org
Michael Byrne, MD
- Recruiting
Robert Wood Johnson/Cancer Institute of New Jersey
New Brunswick, New Jersey, 08901
Matthew Matasar, MD, MS, mm3511@cinj.rutgers.edu
Matthew Matasar, MD, MS
- Recruiting
Yale New Haven Hospital
New Haven, Connecticut, 06510
Aaron Flagg, MD, aron.flagg@yale.edu
Aaron Flagg, MD
- Recruiting
Cohen Children's Medical Center of New York
New Hyde, New York, 11040
Jonathan Fish, MD, jfish1@nshs.edu
Jonathan Fish, MD
- Withdrawn
Tulane Medical Center
New Orleans, Louisiana, 70112
- Recruiting
Children's Hospital of New Orleans/LSUHSC
New Orleans, Louisiana, 70118
Maria Velez, MD, 504-896-9740, mvelez@lsuhsc.edu
Maria Velez, MD
- Recruiting
New York University Langone Medical Center
New York, New York, 10016
Mohammad M Abdul Hay, MD, 312-315-2687, maher.abdulhay@nyulangone.org
Antoine Mesidor, Antoine.Mesidor@nyulangone.org
- Recruiting
New York Presbyterian Hospital at Cornell
New York, New York, 10021
Tsiporah Shore, MD, tbs2001@med.cornell.edu
Tsiporah Shore, MD
- Recruiting
Mount Sinai Medical Center - New York
New York, New York, 10029
Alla Keyzner, MD, alla.keyzner@mssm.edu
Alla Keyzner, MD
- Recruiting
Columbia University Medical Center - Morgan Stanley Children's Hospital
New York, New York, 10032
Monica Bhatia, MD, mb2476@columbia.edu
Monica Bhatia, MD
- Recruiting
Memorial Sloan-Kettering Cancer Center
New York, New York, 10065
Ann Jakubowski, MD, 646-752-5174, jakubowa@mskcc.org
Ann Jakubowski, MD
- Recruiting
Westchester Medical Center
New York, New York, 10595
Mitchell Cairo, MD, 914-594-3640, mitchell_cairo@nymc.edu
Mitchell Cairo, MD
- Active, not recruiting
Children's Hospital and Research Center of Oakland
Oakland, California, 94609
- Recruiting
University of Oklahoma Health Science Center
Oklahoma City, Oklahoma, 73103
Adam Asch, MD, adam-asch@ouhsc.edu
Adam Asch, MD
- Recruiting
University of Nebraska Medical Center
Omaha, Nebraska, 68198-2168
Phyllis Warkenton, MD, pwarkent@unmc.edu
Phyllis Warkenton, MD
- Recruiting
Children's Hospital of Orange County (CHOC)
Orange, California, 92868
Rishikesh Chavan, MD, rishikesh.chavan@choc.org
Rishikesh Chavan, MD
- Recruiting
AdventHealth Orlando
Orlando, Florida, 32804
Rushang Patel, MD, rushang.patel.md@adventhealth.com
Rushang Patel, MD
- Recruiting
Florida Center for Pediatric Cellular Therapy
Orlando, Florida, 32804
Susan Kelly, MD, susan.kelly.md@flhosp.org
Susan Kelly, MD
- Recruiting
Orlando Health Arnold Palmer Hospital for Children
Orlando, Florida, 32806
Rikin Shah, 321-842-9904, rikin.shah@orlandohealth.com
Rikin Shah, MD
- Recruiting
Orlando Health Cancer Institute Bone Marrow Transplant and Cellular Therapy
Orlando, Florida, 32806
Yasser Khaled, MD, yasser.khaled@orlandohealth.com
Yasser Khaled, MD
- Terminated
Advocate Lutheran General Hospital
Park Ridge, Illinois, 60068
- Recruiting
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104
Timothy Olson, MD, 267-426-5516, olsont@email.chop.edu
Timothy Olson, MD
- Recruiting
Phoenix Children's Hospital
Phoenix, Arizona, 85016
Dana Salzberg, MD, 602-546-0920, dsalzberg@phoenixchildrens.com
Dana Salzberg, MD
- Withdrawn
Mayo Clinic Arizona (adults)
Phoenix, Arizona, 85054
- Recruiting
Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, 15224
Paul Szabolcs, MD, Paul.szabolcs@chp.edu
Paul Szabolcs, MD
- Recruiting
West Penn Hospital
Pittsburgh, Pennsylvania, 15224
Prerna Mewawalla, MD, 412-578-4484, pmewawalla26085@direct.ahn.org
Prerna Mewawalla, MD
- Recruiting
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15232
Alison Sehgal, MD, sehgalar@upmc.edu
Alison Sehgal, MD
- Recruiting
University of Pennsylvania/Thomas Jefferson
Pittsburgh, Pennsylvania, 19104
Elizabeth Hexner, MD, elizabeth.hexner@uphs.upenn.edu
Elizabeth Hexner, MD
- Recruiting
Oregon Health & Science University/Doernbecher Children's Hospital
Portland, Oregon, 97239
Eneida Nemecek, MD, nemeceke@ohsu.edu
Eneida Nemecek, MD
- Suspended
Roger Williams Medical Center
Providence, Rhode Island, 02908
- Recruiting
Virginia Commonwealth University
Richmond, Virginia, 23227
John McCarty, MD, 804-828-4596, jmccarty@vcu.edu
John McCarty, MD
- Active, not recruiting
Mayo Clinic Rochester
Rochester, Minnesota, 55905
- Recruiting
Strong Memorial Hospital/University of Rochester
Rochester, New York, 14642-8704
Omar Aljitawi, MD, omar_aljitawi@urmc.rochester.edu
Omar Aljitawi, MD
- Recruiting
Sutter Medical Center
Sacramento, California, 95816
Elias Kiwan, MD, (916) 733-4400, elias.kiwan@sutterhealth.org
Elias Kiwan, MD
- Recruiting
University of Utah
Salt Lake City, Utah, 84132
Ahmad Rayes, MD, ahmad.rayes@hsc.utah.edu
Ahmad Rayes, MD
- Recruiting
The Children's Hospital of San Antonio
San Antonio, Texas, 78207
Martin Andreansky, MD, PhD, martin.andreansky@bcm.edu
Mark Schambura, Mark.schambura@christushealth.org
- Recruiting
Methodist Healthcare System of San Antonio/Texas Transplant Institute
San Antonio, Texas, 78229
Jose Cruz, MD, josecarlos.cruz@hcahealthcare.com
Jose Cruz, MD
- Recruiting
Rady Children's Hospital San Diego
San Diego, California, 92123
Eric Anderson, MD, eanderson@rchsd.org
Eric Anderson, MD
- Active, not recruiting
UCSF (adults)
San Francisco, California, 94143
- Recruiting
UCSF (Peds)
San Francisco, California, 94143
Sandhya Kharbanda, MD, sandhya.kharbanda@ucsf.edu
Sandhya Kharbanda, MD
- Suspended
VA Puget Sound HCS
Seattle, Washington, 98108
- Recruiting
Fred Hutchinson Cancer Research Center
Seattle, Washington, 98109
Ann Dahlberg, MD, adahlber@fredhutch.org
Ann Dahlberg, MD
- Recruiting
Avera Transplant Institute
Sioux Falls, South Dakota, 57105
Waqas Jehangir, MD, FACP, waqas.jehangir@avera.org
Waqas Jehangir, MD, FACP
- Recruiting
Cardinal Glennon Children's Medical Center
St Louis, Missouri, 63104
Deepika Bhatla, MD, dbhatla@slu.edu
Deepika Bhatla, MD
- Suspended
St. Louis University Medical Center
St Louis, Missouri, 63110
- Recruiting
Washington University St. Louis
St Louis, Missouri, 63110
Geoffrey Uy, MD, guy@wustl.edu
Geoffrey Uy, MD
- Recruiting
Washington University/St. Louis Children's Hospital
St Louis, Missouri, 63110
Geoffrey Uy, MD, guy@wustl.edu
Geoffrey Uy, MD
- Recruiting
All Children's Hospital
St. Petersburg, Florida, 33701
Deepakbabu Chellapandian, MD, dchella2@jhmi.edu
Deepakbabu Chellapandian, MD
- Recruiting
Stanford University Medical Center
Stanford, California, 94304
Andrew Rezvani, MD, arezvani@stanford.edu
Andrew Rezvani, MD
- Recruiting
Stony Brook University Hospital
Stony Brook, New York, 11794
Michael Schuster, MD, mschuster@notes.cc.sunysb.edu
Michael Schuster, MD
- Active, not recruiting
H Lee Moffitt Cancer Center
Tampa, Florida, 33612
- Recruiting
Children's Hospital at Montefiore
The Bronx, New York, 10467
Mahvish Rahim, MD, mrahim@montefiore.org
David Loeb, MD, PhD
- Recruiting
University of Arizona Medical Center - Tucson
Tucson, Arizona, 85224
Emmanuel Katsanis, MD, katsanis@peds.arizona.edu
Emmanuel Katsanis, MD
- Recruiting
Children's National Medical Center
Washington D.C., District of Columbia, 20010
David Jacobsohn, MD, dajacobs@childrensnational.org
David Jacobsohn, MD
- Recruiting
University of Kansas
Westwood, Kansas, 66205
Joseph McGuirk, DO, jmcguirk@kumc.edu
Joseph McGuirk, DO
- Withdrawn
Wake Forest University
Winston-Salem, North Carolina, 27157
- Active, not recruiting
University of Massachusetts
Worcester, Massachusetts, 01655
- Terminated
Midwestern Regional Medical Center
Zion, Illinois, 60099
About this study
Official title: A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other Indications
This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.
Read the detailed description
Principal Investigators:
The principal investigators (PIs) will be transplant physicians at all participating U.S. transplant centers.
Study Design:
This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.
Primary Objective:
The primary objective of this study is to examine the incidence of neutrophil recovery of ≥500/mm3 after cord blood transplantation in a multi-institution setting using CBUs that are not Food and Drug Administration (FDA) licensed.
Secondary Objectives:
In patients receiving a non-licensed CBU:
- Assess incidence of transmission of infection
- Assess incidence of serious infusion reaction
- Determine 1 year overall survival after cord blood transplantation
- Assess cumulative incidence of acute graft vs. host disease (GVHD) grades II to IV and grades III to IV
- Assess cumulative incidence of chronic GVHD
- Determine platelet engraftment of >20,000 mcL and >50,000 mcL
- Conditions
- Hematologic Malignancies, Inherited Disorders of Metabolism, Inherited Abnormalities of Platelets, Histiocytic Disorders, Acute Myelogenous Leukemia (AML or ANLL), Acute Lymphoblastic Leukemia (ALL)
- Being tested
- A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs)
- Medical subject headings
- Hematologic Neoplasms, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Disease, Hodgkin Disease, Lymphoma, Non-Hodgkin, Autoimmune Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs)Drug
A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) for transplantation in pediatric and adult patients with hematologic malignancies and other indications
| Study group | Role | What they receive |
|---|---|---|
| Unlicensed CBU | The cohort includes recipients of any age receiving unlicensed cryopreserved cord blood units (CBUs) for designated indications. Receives: Drug: A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Neutrophil recovery of ≥500/mm3 after cord blood transplantation
The primary objective of this access and distribution protocol is to examine the incidence of neutrophil recovery of ≥500/mm3 after cord blood transplantation in a multi-institution setting using CBUs that are not FDA licensed.
Measured: Cord blood engraftment occurs in weeks following transplant is defined as defined as ANC 500/mm3 and is analyzed at 60 days post-transplant.
Neutrophil recovery of ≥500/mm3 after cord blood transplantation
The primary objective of this access and distribution protocol is to examine the incidence of neutrophil recovery of ≥500/mm3 after cord blood transplantation in a multi-institution setting using CBUs that are not FDA licensed.
Measured: Cord blood engraftment occurs in weeks following transplant is defined as defined as ANC 500/mm3 and is analyzed at 100 days post-transplant.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 May 2011 (estimated)
- Study startOct 2011
- Primary completionOct 2041 (estimated)
- Study completionOct 2041 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Hematologic MalignanciesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 99,999 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Center for International Blood and Marrow Transplant Research
- Sponsor type
- Research network
- Collaborators
- National Marrow Donor Program
- Responsible party
- Sponsor
- Investigators
- Heather Stefanski, MD, PhD, Study chair, NMDP/CIBMTR
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01351545
- Sponsor's protocol ID
- 10-CBA
- Status last verified
- Feb 2026
- First submitted
- 9 May 2011
- Last updated
- 6 Jul 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- Yes
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 6 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other Indications
- ClinicalTrials.gov ID
- NCT01351545
- Acronym / sponsor ID
- 10-CBA
- Conditions
- Hematologic Malignancies, Inherited Disorders of Metabolism, Inherited Abnormalities of Platelets, Histiocytic Disorders, Acute Myelogenous Leukemia (AML or ANLL), Acute Lymphoblastic Leukemia (ALL)
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 99,999 participants (estimated)
- Lead sponsor
- Center for International Blood and Marrow Transplant ResearchResearch network
- Collaborators
- National Marrow Donor Program
- Study start
- Oct 2011
- Primary completion
- Oct 2041 (estimated)
- Study completion
- Oct 2041 (estimated)
- First posted
- 11 May 2011 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.
Detailed description
Principal Investigators:
The principal investigators (PIs) will be transplant physicians at all participating U.S. transplant centers.
Study Design:
This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.
Primary Objective:
The primary objective of this study is to examine the incidence of neutrophil recovery of ≥500/mm3 after cord blood transplantation in a multi-institution setting using CBUs that are not Food and Drug Administration (FDA) licensed.
Secondary Objectives:
In patients receiving a non-licensed CBU:
- Assess incidence of transmission of infection
- Assess incidence of serious infusion reaction
- Determine 1 year overall survival after cord blood transplantation
- Assess cumulative incidence of acute graft vs. host disease (GVHD) grades II to IV and grades III to IV
- Assess cumulative incidence of chronic GVHD
- Determine platelet engraftment of >20,000 mcL and >50,000 mcL
Study design
- Observational model
- Other
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Unlicensed CBU | – | Drug: A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs)The cohort includes recipients of any age receiving unlicensed cryopreserved cord blood units (CBUs) for designated indications. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Recipients of unlicensed cryopreserved cord blood units who are being treated as U.S. transplant centers.
Key inclusion criteria (3 listed)
- Disorders affecting the hematopoietic system that are inherited, acquired, or result from myeloablative treatment
- Signed informed consent (and signed assent, if applicable) obtained prior to study enrollment
- Pediatric and adult patients of any age
Key exclusion criteria (4 listed)
- Patients who are receiving only licensed CBUs
- Cord blood transplant recipients at international transplant centers
- Patients who are enrolled on another IND protocol to access the unlicensed CBU(s)
- Patients whose selected unlicensed CBU(s) will be more than minimally manipulated
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs)A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) for transplantation in pediatric and adult patients with hematologic malignancies and other indications | Drug | Unlicensed CBU |
Primary outcome
Neutrophil recovery of ≥500/mm3 after cord blood transplantation
Time frame: Cord blood engraftment occurs in weeks following transplant is defined as defined as ANC 500/mm3 and is analyzed at 60 days post-transplant.
The primary objective of this access and distribution protocol is to examine the incidence of neutrophil recovery of ≥500/mm3 after cord blood transplantation in a multi-institution setting using CBUs that are not FDA licensed.
Neutrophil recovery of ≥500/mm3 after cord blood transplantation
Time frame: Cord blood engraftment occurs in weeks following transplant is defined as defined as ANC 500/mm3 and is analyzed at 100 days post-transplant.
The primary objective of this access and distribution protocol is to examine the incidence of neutrophil recovery of ≥500/mm3 after cord blood transplantation in a multi-institution setting using CBUs that are not FDA licensed.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Jul 2026.
Related trials for Hematologic Malignancies
RecruitingPhase 3
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Acute Promyelocytic Leukemia (APL), Acute Promyelocytic Leukaemia
Enrolling by invitationObservational study
Natural History Study of Early Life Exposures in Agriculture (ELEA)
Prostate Cancer, Leukemia
Not yet recruiting
Micro Assays for HemATology Malignancies Antibody Treatment
Hematological Malignancy
RecruitingObservational study
Cancer in Inherited Bone Marrow Failure Syndromes
Diamond Blackfan Anemia, Dyskeratosis Congenita
Active, not recruitingPhase 1/2
Study to Evaluate the Safety and Preliminary Efficacy of Ibrutinib and Pembrolizumab in Patients With Chronic Lymphocytic Leukemia (CLL) or Mantle Cell Lymphoma (MCL)
Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Elizabeth Fosberg, B.A. contact
Heather Stefanski, MD, PhD study chair
NMDP/CIBMTR
142 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Hematologic Malignancies and Inherited Disorders of Metabolism, run by Center for International Blood and Marrow Transplant Research at 142 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 6 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 142 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Elizabeth Fosberg, B.A. (10-CBA@ndmp.org), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Neutrophil recovery of ≥500/mm3 after cord blood transplantation (time frame: Cord blood engraftment occurs in weeks following transplant is defined as defined as ANC 500/mm3 and is analyzed at 60 days post-transplant.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jul 2026.